The impact of benzodiazepine exposure on treatment retention in an open-access methadone program: A retrospective cohort study.

[1]  E. Wood,et al.  Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials , 2021, Systematic Reviews.

[2]  P. Bach,et al.  Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada , 2021, JAMA network open.

[3]  M. Cerdá,et al.  Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings. , 2021, Journal of substance abuse treatment.

[4]  Rosie P Cornish,et al.  Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records , 2019, PLoS medicine.

[5]  Steven L. Proctor,et al.  Medication Treatment With Methadone or Buprenorphine: Differential Reasons for Premature Discharge , 2019, Journal of addiction medicine.

[6]  P. Kurdyak,et al.  Evaluating the Impact of Prescribed Versus Nonprescribed Benzodiazepine Use in Methadone Maintenance Therapy: Results From a Population-based Retrospective Cohort Study , 2018, Journal of addiction medicine.

[7]  Neelima J. Kale.  Urine Drug Tests: Ordering and Interpreting Results. , 2019, American family physician.

[8]  K. Witkiewitz,et al.  Nonmedical prescription sedative/tranquilizer use in alcohol and opioid use disorders. , 2019, Addictive behaviors.

[9]  Declan T. Barry,et al.  An investigation of an open‐access model for scaling up methadone maintenance treatment , 2018, Addiction.

[10]  J. Eibl,et al.  The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario , 2017, Harm Reduction Journal.

[11]  Lampros Samartzis,et al.  Opioid substitution therapy: Lowering the treatment thresholds. , 2016, Drug and alcohol dependence.

[12]  C. Timko,et al.  Retention in medication-assisted treatment for opiate dependence: A systematic review , 2016, Journal of addictive diseases.

[13]  Scott Proescholdbell,et al.  OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality , 2016 .

[14]  Christopher M. Jones,et al.  Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines. , 2015, American journal of preventive medicine.

[15]  Dara Ganoczy,et al.  Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study , 2015, BMJ : British Medical Journal.

[16]  H. A. Hoffman,et al.  Patterns of Abstinence or Continued Drug Use Among Methadone Maintenance Patients and Their Relation to Treatment Retention , 2014, Journal of psychoactive drugs.

[17]  W. Ling,et al.  Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. , 2014, Addiction.

[18]  S. Schreiber,et al.  Benzodiazepine usage during 19.5 years in methadone maintenance treatment patients and its relation to long-term outcome. , 2014, The Israel journal of psychiatry and related sciences.

[19]  S. Comer,et al.  Polydrug abuse: a review of opioid and benzodiazepine combination use. , 2012, Drug and alcohol dependence.

[20]  C. D’Adamo,et al.  Benzodiazepine Use and Misuse Among Patients in a Methadone Program , 2011, BMC psychiatry.

[21]  M. Agar,et al.  Premature Discharge from Methadone Treatment: Patient Perspectives , 2009, Journal of psychoactive drugs.

[22]  B. Sproule,et al.  The Impact of Benzodiazepine Use on Methadone Maintenance Treatment Outcomes , 2008, Journal of addictive diseases.

[23]  M. Schiff,et al.  Retention and illicit drug use among methadone patients in Israel: a gender comparison. , 2007, Addictive behaviors.

[24]  M. Kreek,et al.  Adolescent and Young Adult Heroin Patients , 2006, Journal of addictive diseases.

[25]  K. Humphreys,et al.  Predictors of retention in methadone programs: a signal detection analysis. , 2006, Drug and alcohol dependence.

[26]  S. Schreiber,et al.  Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. , 2006, Drug and alcohol dependence.

[27]  S. Eisen,et al.  Reliability and Validity of the BASIS-24© Mental Health Survey for Whites, African-Americans, and Latinos , 2006, The Journal of Behavioral Health Services & Research.

[28]  R. Hubbard,et al.  Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). , 2003, Journal of substance abuse treatment.

[29]  M. Gelkopf,et al.  Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic. , 1999, Drug and alcohol dependence.

[30]  M. Torrens,et al.  Retention in a low-threshold methadone maintenance program. , 1996, Drug and alcohol dependence.

[31]  W. Bickel,et al.  Benzodiazepine and sedative use/abuse by methadone maintenance clients. , 1993, Drug and alcohol dependence.

[32]  R. Griffiths,et al.  Diazepam use among methadone maintenance patients: patterns and dosages. , 1981, Drug and alcohol dependence.

[33]  D. Simpson.  Treatment for drug abuse. Follow-up outcomes and length of time spent. , 1981, Archives of general psychiatry.